Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(27 sites)

United States

University of Alabama At Birmingham, Birmingham, Alabama

Medical Dermatology Specialists Phoenix, Phoenix, Arizona

Saguaro Dermatology, Phoenix, Arizona

Uconn Health, Farmington, Connecticut

University of Miami Miller School of Medicine, Miami, Florida